Trial Profile
AV650-018: A Two-Part (Double-Blind Followed by Open-Label), Placebo Controlled, Randomized Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of AV650 (Tolperisone HCl) in Subjects With Spasticity Associated With Multiple Sclerosis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2013
Price :
$35
*
At a glance
- Drugs Tolperisone (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 09 Jan 2013 New trial record